id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2006-N-0238-0008,FDA,FDA-2006-N-0238,Attachment 1 Creation and Development of the Public Service Orphan Drug Human Botulism Immune Globulin re Comment from California Department of Health Services,Supporting & Related Material,C-Comment (Supporting and Related Material),2007-03-19T04:00:00Z,2007,3,,,2025-04-14T16:49:35Z,,0,0,0900006480456e00
FDA-2006-N-0238-0010,FDA,FDA-2006-N-0238,Attachment 2 Human Botulism Immune Globulin for the Treatment of Infant Botulism re Comment from California Department of Health Services,Supporting & Related Material,C-Comment (Supporting and Related Material),2007-03-19T04:00:00Z,2007,3,,,2025-04-14T16:50:01Z,,0,0,0900006480456e03
FDA-2006-N-0238-0006,FDA,FDA-2006-N-0238,Memorandum from Office of Policy to the Division of Dockets Management Request for Extension Comment Period,Other,Memorandum,2007-03-13T04:00:00Z,2007,3,2007-03-12T04:00:00Z,,2025-04-11T22:24:04Z,,0,0,0900006480456d95